Variant report
Variant | nsv465742 |
---|---|
Chromosome Location | chr8:96444602-96456072 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:21)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:21 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr8:96449382-96449610 | IMR90 | lung: | n/a | chr8:96449516-96449527 |
2 | CEBPB | chr8:96449345-96449721 | HepG2 | liver: | n/a | chr8:96449516-96449527 |
3 | CEBPB | chr8:96445313-96445477 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | CEBPB | chr8:96449408-96449593 | A549 | lung: | n/a | chr8:96449516-96449527 |
5 | CTCF | chr8:96446480-96446630 | GM12867 | blood: | n/a | n/a |
6 | EP300 | chr8:96453418-96453429 | GM12878 | blood: | n/a | n/a |
7 | FOS | chr8:96449365-96449506 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOS | chr8:96449402-96449549 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | FOS | chr8:96453896-96454643 | HUVEC | blood vessel: | n/a | chr8:96454386-96454397 chr8:96454437-96454446 |
10 | FOXA1 | chr8:96449356-96449631 | HepG2 | liver: | n/a | n/a |
11 | FOXA2 | chr8:96449379-96449642 | HepG2 | liver: | n/a | n/a |
12 | FOXP2 | chr8:96451989-96452239 | SK-N-MC | brain: | n/a | n/a |
13 | GATA2 | chr8:96454151-96454723 | HUVEC | blood vessel: | n/a | n/a |
14 | JUN | chr8:96454244-96454596 | HUVEC | blood vessel: | n/a | chr8:96454437-96454446 |
15 | POLR2A | chr8:96454306-96454509 | HUVEC | blood vessel: | n/a | n/a |
16 | POLR2A | chr8:96453568-96453755 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | POLR2A | chr8:96454110-96454529 | HUVEC | blood vessel: | n/a | n/a |
18 | POLR2A | chr8:96444556-96444702 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | SETDB1 | chr8:96453976-96454448 | U2OS | brain: | n/a | n/a |
20 | STAT1 | chr8:96447792-96447830 | GM12878 | blood: | n/a | n/a |
21 | USF2 | chr8:96446187-96446189 | K562 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PLEKHF2-2 | chr8:96444854-96445008 | ENSG00000253773.1 |
2 | lnc-PLEKHF2-2 | chr8:96444854-96445008 | NONHSAT127831 |
3 | lnc-PLEKHF2-2 | chr8:96444854-96445008 | NONHSAT127835 |
4 | lnc-PLEKHF2-2 | chr8:96444854-96444894 | ENSG00000253773.1 |
5 | lnc-PLEKHF2-2 | chr8:96444854-96445008 | NONHSAT127837 |
6 | lnc-PLEKHF2-2 | chr8:96444865-96445008 | ENSG00000253773.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253773 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3133754 | chr8:96444602-96444603 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs111686385 | chr8:96444628-96444629 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs10110745 | chr8:96444664-96444665 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs550521153 | chr8:96444708-96444709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563666402 | chr8:96444716-96444717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147867677 | chr8:96444740-96444741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573769083 | chr8:96444762-96444763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139319000 | chr8:96444767-96444768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150004198 | chr8:96444777-96444778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536867523 | chr8:96444790-96444791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145372201 | chr8:96444800-96444801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371150713 | chr8:96444817-96444818 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556439237 | chr8:96444878-96444879 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs182358495 | chr8:96444884-96444885 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs536138148 | chr8:96444915-96444916 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs556080744 | chr8:96444944-96444945 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs10113800 | chr8:96445002-96445003 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs554126462 | chr8:96445049-96445050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538209072 | chr8:96445087-96445088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558544679 | chr8:96445088-96445089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs76082190 | chr8:96445093-96445094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541154167 | chr8:96445137-96445138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564109168 | chr8:96445178-96445179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186001833 | chr8:96445202-96445203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531602982 | chr8:96445203-96445204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373829209 | chr8:96445204-96445205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370206319 | chr8:96445219-96445220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11778374 | chr8:96445220-96445221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs11778375 | chr8:96445221-96445222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11774175 | chr8:96445227-96445228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540355241 | chr8:96445243-96445244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11780792 | chr8:96445250-96445251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149189590 | chr8:96445262-96445263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs11774183 | chr8:96445266-96445267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138131211 | chr8:96445272-96445273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192080908 | chr8:96445283-96445284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12674640 | chr8:96445293-96445294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75894689 | chr8:96445294-96445295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75348871 | chr8:96445295-96445296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374766850 | chr8:96445313-96445314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552257009 | chr8:96445316-96445317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560308664 | chr8:96445380-96445381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374608338 | chr8:96445396-96445397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145190015 | chr8:96445404-96445405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183927468 | chr8:96445411-96445412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs386413403 | chr8:96445439-96445440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567114613 | chr8:96445458-96445459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386413404 | chr8:96445460-96445461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs55758720 | chr8:96445461-96445462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368665289 | chr8:96445462-96445463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
head and neck squamous cell carcinoma | 19451471 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 17847001 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 17142309 | CNVD |
Malignant melanoma | 17260012 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:96443200-96447800 | Weak transcription | Fetal Lung | lung |
2 | chr8:96443400-96445000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr8:96443800-96447400 | Weak transcription | Rectal Smooth Muscle | rectum |
4 | chr8:96444400-96446600 | Weak transcription | Colon Smooth Muscle | Colon |
5 | chr8:96444400-96447600 | Weak transcription | Ovary | ovary |
6 | chr8:96444600-96446800 | Weak transcription | Fetal Stomach | stomach |
7 | chr8:96444600-96449200 | Weak transcription | Stomach Smooth Muscle | stomach |
8 | chr8:96446600-96448200 | Enhancers | Colon Smooth Muscle | Colon |
9 | chr8:96446800-96447000 | Enhancers | Fetal Stomach | stomach |
10 | chr8:96447000-96447400 | Weak transcription | Fetal Stomach | stomach |
11 | chr8:96447400-96448000 | Enhancers | Rectal Smooth Muscle | rectum |
12 | chr8:96447400-96448800 | Enhancers | Fetal Stomach | stomach |
13 | chr8:96447600-96449800 | Enhancers | Ovary | ovary |
14 | chr8:96447800-96449600 | Enhancers | Fetal Lung | lung |
15 | chr8:96448800-96450000 | Enhancers | Liver | Liver |
16 | chr8:96449200-96449400 | Enhancers | Stomach Smooth Muscle | stomach |
17 | chr8:96451600-96451800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr8:96453800-96454800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
19 | chr8:96453800-96455400 | Enhancers | HUVEC | blood vessel |
20 | chr8:96454200-96454800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr8:96454200-96454800 | Enhancers | Osteobl | bone |
22 | chr8:96454400-96454800 | Enhancers | Muscle Satellite Cultured Cells | -- |
23 | chr8:96454800-96456200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
24 | chr8:96455000-96456000 | Enhancers | Right Ventricle | heart |
25 | chr8:96455800-96456800 | Enhancers | Fetal Heart | heart |